Anthracycline as second line chemotherapy (CT) for metastatic breast cancer (MBC) patients previously treated with taxotere (TXT)

被引：0
|
作者：
Delecroix, V
Fumoleau, P
Perrocheau, G
Azli, N
Fety, R
Priou, F
Maugard, C
Riva, A
Lemevel, B
机构：
[1] CTR RENE GAUDUCHEAU,F-44035 NANTES,FRANCE
[2] RHONE POULENC RORER,ANTONY,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [1] Activity of gemcitabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containing regimens
    Spielmann, M
    Kalla, S
    LlombartCussac, A
    Espie, M
    Namer, M
    Ferrero, JM
    Cuvier, C
    Fumoleau, P
    Ponzio, A
    Kayitalire, L
    Pouillart, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 663 - 663
  • [2] Taxotere as second-line chemotherapy for metastatic breast cancer.
    Culine, S
    [J]. REVUE DE MEDECINE INTERNE, 1999, 20 (03): : 277 - 280
  • [3] Preliminary efficacy and tolerance results of docetaxel (taxotere) (TXT) in heavily pretreated metastatic breast cancer patients (MBC)
    Chahine, A
    Trandafir, L
    Errihani, H
    DesGuetz, G
    Musset, M
    Jasmin, C
    Cvitkovic, E
    Misset, JL
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 382 - 382
  • [4] Preliminary data of a phase II randomized trial of taxotere (TXT) and doxorubicin (DOX) given simultaneously or sequentially as 1st line chemotherapy (CT) for metastatic breast cancer (MBC)
    Koroleva, I
    Wojtukiewicz, M
    Zaluski, J
    Korytova, L
    Biakhov, M
    Gadel-Mawia, N
    Gouda, Y
    Krishtopin, V
    Dubois, C
    Blanc, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S317 - S317
  • [5] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Martina Baur
    Allan T. van Oosterom
    Véronique Diéras
    Michele Tubiana-Hulin
    R. Charles Coombes
    Thomas Hatschek
    Michael Murawsky
    May Klink-Alakl
    Marcus Hudec
    Christian Dittrich
    [J]. Journal of Cancer Research and Clinical Oncology, 2008, 134 : 125 - 135
  • [6] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Baur, Martina
    van Oosterom, Allan T.
    Dieras, Veronique
    Tubiana-Hulin, Michele
    Coombes, R. Charles
    Hatschek, Thomas
    Murawsky, Michael
    Klink-Alakl, May
    Hudec, Marcus
    Dittrich, Christian
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (02) : 125 - 135
  • [7] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PH
    De Jong, RS
    Honkoop, A
    Rodenburg, C
    Rooda, SE
    Coenen, J
    De Jong, PC
    Douma, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 74S - 74S
  • [8] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PHTHJ
    Jong, PC
    Jong, RS
    Honkoop, AH
    Coenen, JLLM
    Rodenburg, CJ
    Rooda, SJE
    Douma, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 60S - 60S
  • [9] Phase III study:: Taxotere® (TXT) versus 5-Fluorouracil plus navelbine (FUN) in patients (pts) with metastatic breast cancer (MBC) as 2nd line chemotherapy (CT) (preliminary results)
    Monnier, A
    Bonneterre, J
    Roche, H
    Fargeot, P
    Namer, M
    Guastalla, JP
    Rios, M
    Serin, D
    Culine, S
    Tubiana, M
    Eymard, JC
    Assadourian, S
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 12 - 12
  • [10] Weekly application of docetaxel in patients with previously treated metastatic breast cancer (MBC).
    Krapfl-Gast, AS
    Grischke, EM
    Bastert, G
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 30 - 30
12345